rs7305016

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001031628.2(SMAGP):​c.35-1928T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.528 in 151,908 control chromosomes in the GnomAD database, including 22,421 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 22421 hom., cov: 30)

Consequence

SMAGP
NM_001031628.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.232

Publications

8 publications found
Variant links:
Genes affected
SMAGP (HGNC:26918): (small cell adhesion glycoprotein) Located in cell junction; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
DAZAP2 (HGNC:2684): (DAZ associated protein 2) This gene encodes a proline-rich protein which interacts with the deleted in azoospermia (DAZ) and the deleted in azoospermia-like gene through the DAZ-like repeats. This protein also interacts with the transforming growth factor-beta signaling molecule SARA (Smad anchor for receptor activation), eukaryotic initiation factor 4G, and an E3 ubiquitinase that regulates its stability in splicing factor containing nuclear speckles. The encoded protein may function in various biological and pathological processes including spermatogenesis, cell signaling and transcription regulation, formation of stress granules during translation arrest, RNA splicing, and pathogenesis of multiple myeloma. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001031628.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001031628.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAGP
NM_001031628.2
MANE Select
c.35-1928T>C
intron
N/ANP_001026798.1Q0VAQ4
SMAGP
NM_001033873.1
c.35-1928T>C
intron
N/ANP_001029045.1Q0VAQ4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAGP
ENST00000603798.6
TSL:1 MANE Select
c.35-1928T>C
intron
N/AENSP00000475068.1Q0VAQ4
SMAGP
ENST00000398453.7
TSL:1
c.35-1928T>C
intron
N/AENSP00000381471.2Q0VAQ4
SMAGP
ENST00000380103.4
TSL:1
n.*40-1928T>C
intron
N/AENSP00000369446.4A0A0A0MRX0

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80177
AN:
151790
Hom.:
22413
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.341
Gnomad AMI
AF:
0.664
Gnomad AMR
AF:
0.525
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.609
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.635
Gnomad OTH
AF:
0.572
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.528
AC:
80213
AN:
151908
Hom.:
22421
Cov.:
30
AF XY:
0.525
AC XY:
38991
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.341
AC:
14137
AN:
41420
American (AMR)
AF:
0.525
AC:
8013
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2225
AN:
3470
East Asian (EAS)
AF:
0.371
AC:
1914
AN:
5154
South Asian (SAS)
AF:
0.609
AC:
2928
AN:
4808
European-Finnish (FIN)
AF:
0.554
AC:
5844
AN:
10558
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.635
AC:
43157
AN:
67936
Other (OTH)
AF:
0.572
AC:
1204
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
1826
3653
5479
7306
9132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
45856
Bravo
AF:
0.513
Asia WGS
AF:
0.492
AC:
1713
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.2
DANN
Benign
0.37
PhyloP100
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7305016;
hg19: chr12-51642543;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.